Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 3
1971 2
1972 3
1974 3
1975 8
1976 5
1977 2
1978 3
1979 14
1980 18
1981 12
1982 14
1983 19
1984 9
1985 13
1986 10
1987 15
1988 27
1989 12
1990 25
1991 30
1992 38
1993 15
1994 11
1995 13
1996 10
1997 8
1998 15
1999 6
2000 9
2001 4
2002 14
2003 11
2004 10
2005 5
2006 3
2007 4
2008 6
2009 5
2010 6
2011 5
2012 3
2013 8
2014 7
2015 4
2016 7
2017 7
2018 5
2019 3
2020 5
2021 4
2022 5
2023 2
2024 4
2025 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

504 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X, Zhong G, Yao H, Wu J, Ye S. Lv X, et al. Int J Clin Pharmacol Ther. 2021 Nov;59(11):725-733. doi: 10.5414/CP203986. Int J Clin Pharmacol Ther. 2021. PMID: 34448694 Clinical Trial.
Liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was applied to determine the plasma concentration of cefalexin. PhoenixWinNonlin software (V7.0) was used to calculate the pharmacokinetic parameters of cefalexin using the non-compartmental model (NCA), an …
Liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was applied to determine the plasma concentration of cefalexin. PhoenixWi …
Interventions for bacterial folliculitis and boils (furuncles and carbuncles).
Lin HS, Lin PT, Tsai YS, Wang SH, Chi CC. Lin HS, et al. Cochrane Database Syst Rev. 2021 Feb 26;2(2):CD013099. doi: 10.1002/14651858.CD013099.pub2. Cochrane Database Syst Rev. 2021. PMID: 33634465 Free PMC article.
For risk of severe adverse events leading to treatment withdrawal, there may be little to no difference between cefdinir versus cefalexin after 17 to 24 days (1/191 versus 1/200, RR 1.05, 95% CI 0.07 to 16.62; 391 participants; 1 study; low-certainty evidence). ...We are u …
For risk of severe adverse events leading to treatment withdrawal, there may be little to no difference between cefdinir versus cefalexin …
Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials.
Shu Z, Cao J, Li H, Chen P, Cai P. Shu Z, et al. Arch Dermatol Res. 2024 Sep 6;316(8):603. doi: 10.1007/s00403-024-03317-1. Arch Dermatol Res. 2024. PMID: 39240378 Free PMC article.
Antibiotics including azithromycin, cefaclor, cephalexin, cloxacillin, erythromycin, cephalexin plus trimethoprim-sulfamethoxazole, cephalexin plus placebo, flucloxacillin, clindamycin, ceftriaxone, penicillin, roxithromycin, and pristinamycin were assessed r …
Antibiotics including azithromycin, cefaclor, cephalexin, cloxacillin, erythromycin, cephalexin plus trimethoprim-sulfamethoxa …
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.
Jo JH, Harkins CP, Schwardt NH, Portillo JA; NISC Comparative Sequencing Program; Zimmerman MD, Carter CL, Hossen MA, Peer CJ, Polley EC, Dartois V, Figg WD, Moutsopoulos NM, Segre JA, Kong HH. Jo JH, et al. Sci Transl Med. 2021 Dec 22;13(625):eabd8077. doi: 10.1126/scitranslmed.abd8077. Epub 2021 Dec 22. Sci Transl Med. 2021. PMID: 34936382 Free PMC article. Clinical Trial.
In a prospective, randomized study of four clinically relevant antibiotic regimens [doxycycline (20 mg or 100 mg), cephalexin, or trimethoprim/sulfamethoxazole], we investigated microbial alterations on skin after administration of systemic antibiotics to healthy human vol …
In a prospective, randomized study of four clinically relevant antibiotic regimens [doxycycline (20 mg or 100 mg), cephalexin, or tri …
Effect of Post-Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial.
Valent AM, DeArmond C, Houston JM, Reddy S, Masters HR, Gold A, Boldt M, DeFranco E, Evans AT, Warshak CR. Valent AM, et al. JAMA. 2017 Sep 19;318(11):1026-1034. doi: 10.1001/jama.2017.10567. JAMA. 2017. PMID: 28975304 Free PMC article. Clinical Trial.
OBJECTIVE: To determine rates of SSI among obese women who receive prophylactic oral cephalexin and metronidazole vs placebo for 48 hours following cesarean delivery. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind clinical trial comparing oral cephalexin …
OBJECTIVE: To determine rates of SSI among obese women who receive prophylactic oral cephalexin and metronidazole vs placebo for 48 h …
Prophylactic Oral Cephalexin and Metronidazole Compared With Placebo After Cesarean Delivery to Reduce Infection Complications in Women With Obesity: A Randomized Controlled Trial.
Saad AF, Goldman B, Spencer N, Kuhlmann M, McDonnold M, Saade GR. Saad AF, et al. Obstet Gynecol. 2025 May 22;146(1):113-120. doi: 10.1097/AOG.0000000000005936. Obstet Gynecol. 2025. PMID: 40403315 Clinical Trial.
OBJECTIVE: To compare prophylactic oral cephalexin and metronidazole with placebo for 48 hours after cesarean delivery following membrane rupture on the frequency of composite infection morbidity postpartum among pregnant individuals with obesity. ...Participants were assi …
OBJECTIVE: To compare prophylactic oral cephalexin and metronidazole with placebo for 48 hours after cesarean delivery following memb …
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. Health Technol Assess. 2022 May;26(23):1-172. doi: 10.3310/QOIZ6538. Health Technol Assess. 2022. PMID: 35535708 Free article. Clinical Trial.
INTERVENTIONS: A central randomisation system allocated participants 1 : 1 to the experimental (methenamine hippurate: 1 g twice daily) or control (once-daily low-dose antibiotics: 50/100 mg of nitrofurantoin, 100 mg of trimethoprim or 250 mg of cefalexin) arm. Crossover b …
INTERVENTIONS: A central randomisation system allocated participants 1 : 1 to the experimental (methenamine hippurate: 1 g twice daily) or c …
Effect of prophylactic cefalexin treatment on the development of bacterial infection in acute radiation-induced dermatitis in dogs: a blinded randomized controlled prospective clinical trial.
Keyerleber MA, Ferrer L. Keyerleber MA, et al. Vet Dermatol. 2018 Feb;29(1):37-e18. doi: 10.1111/vde.12492. Epub 2017 Sep 18. Vet Dermatol. 2018. PMID: 28921723 Clinical Trial.
Dogs were randomized to receive either prophylactic cefalexin (22 mg/kg twice daily) beginning halfway through the prescribed radiotherapy course (cohort A) or to serve as controls (cohort B). ...CONCLUSIONS AND CLINICAL IMPORTANCE: Prophylactic use of cefalexin for …
Dogs were randomized to receive either prophylactic cefalexin (22 mg/kg twice daily) beginning halfway through the prescribed radioth …
Transurethral prostatectomy in patients with preoperative bacteriuria: double-blind study with oral fleroxacin and cefalexin.
Viitanen J, Malminiemi K, Kallio J, Puolakka VM, Rajala P, Tammela TL. Viitanen J, et al. Chemotherapy. 1998 Jan-Feb;44(1):69-75. doi: 10.1159/000007093. Chemotherapy. 1998. PMID: 9444412 Clinical Trial.
The therapy consisted of 7 days of oral fleroxacin 400 mg once a day or cefalexin 500 mg three times daily. After 2 weeks, 62% of the urine samples were sterile in the fleroxacin groups but only 37% in the cefalexin group (p = 0.047). Patients in the cefalexin …
The therapy consisted of 7 days of oral fleroxacin 400 mg once a day or cefalexin 500 mg three times daily. After 2 weeks, 62% of the …
Antibiotics for mastitis in breastfeeding women.
Jahanfar S, Ng CJ, Teng CL. Jahanfar S, et al. Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD005458. doi: 10.1002/14651858.CD005458.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450563 Free PMC article.
504 results